FLT3 and myelodysplastic syndrome: While the prognostic impact of RAS mutations remains debated, their acquisition or clonal expansion, much like FLT3 mutations, is frequently observed during the transition from myelodysplastic syndromes (MDS) to AML, typically correlating with a poor prognosis (64).